Current Use of Carbon-Based Materials for Biomedical Applications—A Prospective and Review

Among a large number of current biomedical applications in the use of medical devices, carbon-based nanomaterials such as graphene (G), graphene oxides (GO), reduced graphene oxide (rGO), and carbon nanotube (CNT) are frontline materials that are suitable for developing medical devices. Carbon Based...

Full description

Saved in:
Bibliographic Details
Published in:Processes 2020-03, Vol.8 (3), p.355
Main Authors: Rajakumar, Govindasamy, Zhang, Xiu-Hua, Gomathi, Thandapani, Wang, Sheng-Fu, Azam Ansari, Mohammad, Mydhili, Govindarasu, Nirmala, Gnanasundaram, Alzohairy, Mohammad A., Chung, Ill-Min
Format: Article
Language:English
Subjects:
Biocompatibility
Biomedical materials
Biomedical research
Biomolecules
Biosensors
Cancer therapies
Carbon
Carbon nanotubes
Composite materials
Diamonds
Drug delivery
Drug delivery systems
Drugs
Graphene
Heat conductivity
Hybridization
Hydrogels
Medical electronics
Medical equipment
Nanomaterials
Nanotechnology
Quantum dots
Tissue engineering
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Among a large number of current biomedical applications in the use of medical devices, carbon-based nanomaterials such as graphene (G), graphene oxides (GO), reduced graphene oxide (rGO), and carbon nanotube (CNT) are frontline materials that are suitable for developing medical devices. Carbon Based Nanomaterials (CBNs) are becoming promising materials due to the existence of both inorganic semiconducting properties and organic π-π stacking characteristics. Hence, it could effectively simultaneously interact with biomolecules and response to the light. By taking advantage of such aspects in a single entity, CBNs could be used for developing biomedical applications in the future. The recent studies in developing carbon-based nanomaterials and its applications in targeting drug delivery, cancer therapy, and biosensors. The development of conjugated and modified carbon-based nanomaterials contributes to positive outcomes in various therapies and achieved emerging challenges in preclinical biomedical applications. Subsequently, diverse biomedical applications of carbon nanotube were also deliberately discussed in the light of various therapeutic advantages.
ISSN:2227-9717
2227-9717
DOI:10.3390/pr8030355